
Tranexamic acid in arthroscopic repair of rotator cuff tears in the shoulder: a randomized trial
CirurgiaResumo original em inglês
O que aconteceu
The aim of this study was to determine the effectiveness of tranexamic acid in improving intraoperative visual clarity in patients undergoing arthroscopic repair of rotator cuff tears.
This prospective, randomized, double-blinded clinical trial was conducted in Brazil, between July 2020 and September 2022, including patients who underwent surgery for arthroscopic repair of rotator cuff tears.
O que encontraram
In total, 20 patients were included in each group: control, oral, and intravenous. There were no statistically significant differences between groups regarding intraoperative interventions, including duration of surgery, anesthesia time, number of ablations, increase in irrigation pump pressure, or total volume of irrigating solution used. Likewise, no differences were observed between groups in the assessment of visual clarity, either subjective (initial, final, and median) or objective, although the groups that received tranexamic acid had slightly lower average turbidity compared to the control group.
Por que isso importa
Tranexamic acid use did not demonstrate benefits concerning the objective/subjective visual clarity between the evaluated groups.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Tranexamic acid in arthroscopic repair of rotator cuff tears in the shoulder: a randomized trial
Aloísio Rosado Filho, Tércio Maia Sousa, João Nogueira Neto, Luciana Salles Branco-de-Almeida, Caio Marcio Barros de Oliveira, Marcelo Souza De Andrade, Ed Carlos Rey Moura, Almir Vieira Dibai Filho, Plínio da Cunha Leal
Descritores MeSH
- Antifibrinolytic Agents
- Arthroscopy
- Tranexamic Acid
- Rotator Cuff Injuries
- Humans
- Male
- Middle Aged
- Prospective Studies
- Treatment Outcome
- Aged